PROFESSIONAL HEALTH

Finding some really novel targets to generate innovative therapeutics to help cancer patients

CANCER TREATMENT

WHAT IS CANCER?

One defining feature of cancer is the rapid creation of abnormal cells that grow beyond their usual boundaries, and which can then invade adjoining parts of the body and spread to and which can then invade adj other organs, the latter process is being referred to as metastasizing.

HOW CAN IMMUNOPHARMA HELP?

As the cost of treatment for cancer is growing, the search for immune-stimulating substances has become a top priority for everyone. AndoSan™ has been extensively used as an adjuvant to alleviate the side-effects of chemotherapy treatment and ImmunoPharma has experienced that several individuals have lived longer than expected when using AndoSan in combination with other cancer treatments.

ImmunoPharma is still lacking human clinical trial results in this area. Results of recent cell culture and animal studies has opened up possibilities of getting AndoSan™ included in human clinical trials.

  • Asset 5

    Cancer is the result between a person’s genetic factor with ageing Ulceration within

  • Asset 6

    Cancer is a generic term of a group of diseases and may lead to death

  • Artboard 1

    Cancer patients live longer when AndoSan™ has been used in combination with other treatments

INFLAMMATORY BOWEL DISEASE

WHAT IS CANCER?

Inflammatory Bowel Disease, represented by Crohn’s disease and Ulcerative Colitis, are chronic, idiopathic inflammatory conditions, which probably involve an immune reaction of the body against its own gastrointestinal tract.

HOW CAN IMMUNOPHARMA HELP?

IBD is most commonly treated through medication with steroids or immunosuppressants. Current medical treatment is associated with potentially very serious side effects the interest in alternative treatments is therefore very high. AndoSan™, however, has proven to reduce the inflammatory effect in the bowel and by that reduces the physical impact of the patient.

  • Asset 4

    IBD is a group of inflammatory condition of the colon and small intestine

  • Asset 5

    Patients with IBD will benefit from using AndoSan™ has it has proven to reduce the inflammatory effect in the bowel

Read about our branch in Consumer Health

See more